Related Experiment Video
Updated: Jun 30, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
RNA-binding proteins potentially regulate the alternative splicing of cell cycle-associated genes in proliferative
Ning Yang1, Ningzhi Zhang1, Guojing Lu1
1Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Abstract:
RNA-binding proteins (RBPs) contribute to the pathogenesis of proliferative diabetic retinopathy (PDR) by regulating gene expression through alternative splicing events (ASEs). However, the RBPs differentially expressed in PDR and the underlying mechanisms remain unclear. Thus, this study aimed to identify the differentially expressed genes in the neovascular membranes (NVM) and retinas of patients with PDR. The public transcriptome dataset GSE102485 was downloaded from the Gene Expression Omnibus database, and samples of PDR and normal retinas were analyzed. A mouse model of oxygen-induced retinopathy was used to confirm the results. The top 20 RBPs were screened for co-expression with alternative splicing genes (ASGs). A total of 403 RBPs were abnormally expressed in the NVM and retina samples. Functional analysis demonstrated that the ASGs were enriched in cell cycle pathways. Cell cycle-associated ASEs and an RBP-AS regulatory network, including 15 RBPs and their regulated ASGs, were extracted. Splicing factor proline/glutamine rich (SFPQ), microtubule-associated protein 1 B (MAP1B), heat-shock protein 90-alpha (HSP90AA1), microtubule-actin crosslinking factor 1 (MACF1), and CyclinH (CCNH) expression remarkably differed in the mouse model. This study provides novel insights into the RBP-AS interaction network in PDR and for developing screening and treatment options to prevent diabetic retinopathy-related blindness.
Insights
RNA-binding proteins (RBPs) drive proliferative diabetic retinopathy (PDR) by altering gene expression. This study identified key RBPs and their targets involved in cell cycle pathways, offering new therapeutic strategies for PDR.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- RNA-binding proteins (RBPs) are implicated in proliferative diabetic retinopathy (PDR) pathogenesis via alternative splicing events (ASEs).
- The specific RBPs involved in PDR and their regulatory mechanisms remain largely uncharacterized.
Purpose of the Study:
- To identify differentially expressed RBPs and alternative splicing genes (ASGs) in PDR neovascular membranes (NVM) and retinas.
- To elucidate the RBP-AS regulatory network in PDR pathogenesis.
Main Methods:
- Analysis of the public transcriptome dataset GSE102485 (PDR vs. normal retinas).
- Screening for co-expression between top RBPs and ASGs.
- Validation using an oxygen-induced retinopathy mouse model.
Main Results:
- Identified 403 abnormally expressed RBPs in PDR NVM and retinal samples.
- Functional analysis revealed enrichment of ASGs in cell cycle pathways.
- Constructed an RBP-AS regulatory network comprising 15 RBPs and their target ASGs, with notable differential expression of SFPQ, MAP1B, HSP90AA1, MACF1, and CCNH in the mouse model.
Conclusions:
- Established a novel RBP-AS interaction network crucial for PDR development.
- Highlights the role of cell cycle-associated ASEs regulated by specific RBPs in PDR.
- Provides insights for developing diagnostic and therapeutic strategies to prevent PDR-related blindness.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Negative Regulator Molecules
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression at Multiple Steps
What is Gene Expression?

